Abstract
In order to prevent and treat cardiac diseases, the author proposed strategies to invent cardiovascular drugs targeting cardiac gap junctions through summarizing the functions, physiology and pathophysiology of cardiac gap junctions. The 5 principle strategies to invent cardiovascular drugs that are suggested have great potentialities to be used as novel proposals to treat and prevent cardiac diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wit A.L., Duffy H.S., Drug Development for Treatment of Cardiac Arrhythmias. Targeting the Gap Junctions. Am. J. Physiol. Heart Circ. Physiol., 2007, (in press)
Kanno S., Saffitz JE., The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc. Pathol., 2001, 10, 169–177.
Teunissen B.E., Bierhuizen M.F., Transcriptional control of myocardial connexins. Cardiovasc. Res., 2004, 62, 246–255
Dhein S., Polontchouk L., Salameh A., Haefliger J.A., Pharmacological modulation and differential regulation of the cardiac gap junction proteins connexin 43 and connexin 40. Biol. Cell., 2002, 94, 409–422
Garcia-Dorado D., Ruiz-Meana M., Padilla F., Rodriguez-Sinovas A., Mirabet M., Gap junctionmediated intercellular communication in ischemic preconditioning. Cardiovasc. Res., 2002, 55, 456–465
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Han-You, X. Strategies to invent cardiovascular drugs targeting cardiac gap junctions. cent.eur.j.med 3, 254–256 (2008). https://doi.org/10.2478/s11536-007-0064-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11536-007-0064-9